Patents by Inventor Margarita A. Morozova

Margarita A. Morozova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of 7-fluoro-8-chloro-5H-dibenzo [B,E,] [1,4] diazepine and use thereof
    Patent number: 10391101
    Abstract: This present disclosure generally relates to medicine, and in particular to pharmacology and psychiatry, and discloses active agents and related methods of treatment which can be used for the treatment of treatment-resistant forms of schizophrenia. In some exemplary aspects, such treatments allow for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, without causing severe side effects that limit their use, such as sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: August 27, 2019
    Assignee: VALENTEK LLC
    Inventors: Maksim E. Zapolski, Margarita A. Morozova, Allan G. Beniashvili
  • DERIVATIVES OF 7-FLUORO-8-CHLORO-5H-DIBENZO [B,E,] [1,4] DIAZEPINE AND USE THEREOF
    Publication number: 20170196883
    Abstract: This present disclosure generally relates to medicine, and in particular to pharmacology and psychiatry, and discloses active agents and related methods of treatment which can be used for the treatment of treatment-resistant forms of schizophrenia. In some exemplary aspects, such treatments allow for eliminating both the positive and negative symptoms of schizophrenia, and cognitive disorders, without causing severe side effects that limit their use, such as sedation, tachycardia, orthostatism, agranulocytosis and sialorrhea.
    Type: Application
    Filed: March 10, 2017
    Publication date: July 13, 2017
    Inventors: Maksim E. ZAPOLSKI, Margarita A. MOROZOVA, Allan G. BENIASHVILI
  • COMBINATION FOR THE PROPHYLAXIS AND TREATMENT OF BEHAVIOURAL, MENTAL, AND COGNITIVE DISORDERS
    Publication number: 20150250763
    Abstract: The invention relates to the field of pharmacology and practical medicine, namely, to the combined use of pharmaceutical compositions exhibiting a neurotropic action, alleviating manifestations of mental, behavioral, cognitive disorders in cases of organic damage of various origin to the central nervous system. The combination comprises Memantine and Melatonin in therapeutically efficient quantities. The combination enables to raise disease treatment effectiveness. 1 independent claim, 2 dependent claims. 2 examples, 7 tables.
    Type: Application
    Filed: November 7, 2012
    Publication date: September 10, 2015
    Inventors: Margarita MOROZOVA, Allan Gerovich BENIASHVILI, Maxim Eduardovich ZAPOLSKY
  • METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA USING ANTIPSYCHOTIC COMBINATION THERAPY
    Publication number: 20110269777
    Abstract: The present invention relates to combination therapies and methods for treating, preventing and/or delaying the onset and/or development of schizophrenia, wherein the combination therapies comprise a hydrogenated pyrido[4,3-b]indole or a pharmaceutically acceptable salt thereof, such as dimebon, and an antipsychotic.
    Type: Application
    Filed: August 1, 2008
    Publication date: November 3, 2011
    Inventors: Sergey O. Bachurin, Vladimir V. Grigoriev, Margarita A. Morozova, Allan G. Benia
  • Methods and compositions for treating schizophrenia
    Publication number: 20070225316
    Abstract: The present invention relates to methods and compositions useful for treating, preventing and/or delaying the onset and/or development of schizophrenia by administering a hydrogenated pyrido[4,3-b]indole, such as dimebon, or a pharmaceutically acceptable salt thereof, to an individual.
    Type: Application
    Filed: January 25, 2007
    Publication date: September 27, 2007
    Inventors: Sergei Bachurin, Vladimir Grigoriev, Margarita Morozova, Allan Beniashvili